Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › WI › Greenfield › NPI 1770506669
Supplier

Advanced Pain Management SC

Advanced Pain Management SC was paid $3.74M by Medicaid between Jan 2018 and Nov 2020, across 45 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 33% of everything it billed.

33Billing provider infoADVANCED PAIN MANAGEMENT SC
GREENFIELD, WI 53221
33aNPI1770506669assigned 07/25/2006
28Total paid$3.74M
24GClaims130,284
24DCodes billed45
24AFirst – last monthJan 2018 – Nov 2020
Compared with peers

Next to other Durable Medical Equipment & Medical Supplies providers in Wisconsin

Rank by total paid#6 of 451
Median peer was paid$10K
This provider vs. median390×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official LAL, VISHAL controls 17+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$100K$200K$300K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201854,949$1.64M
201950,627$1.50M
202024,708$600K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 33% 51,418 41,367 $1.23M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 10% 26,610 20,992 $386K
64635 8.4% 2,184 1,431 $313K
64483 5.0% 2,147 1,569 $187K
64493 4.8% 2,272 1,697 $179K
62323 4.7% 1,655 1,304 $177K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 4.3% 5,486 4,439 $161K
64636 3.9% 3,086 1,255 $145K
27096 3.7% 1,793 1,385 $137K
99152 3.1% 9,133 6,329 $117K
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 2.6% 1,909 1,601 $98K
64494 2.2% 2,194 1,628 $82K
33 more codes
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 2.1% 1,722 $80K
01936 2.1% 1,645 $79K
64495 1.3% 1,230 $48K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 1.2% 660 $47K
20610 1.2% 1,729 $44K
99203 Doctor's office visit, new patient (routine) 1.1% 1,068 $42K
J7999 Compounded drug, not otherwise classified 1.0% 1,259 $38K
62370 <1% 1,429 $20K
77002 <1% 1,714 $17K
76942 <1% 1,212 $15K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 879 $14K
64633 <1% 117 $12K
99441 <1% 2,408 $12K
90791 Psychiatric diagnostic evaluation <1% 406 $12K
99442 <1% 846 $8K
64484 <1% 148 $7K
64490 <1% 69 $6K
62321 <1% 61 $6K
90834 Psychotherapy session, about 45 minutes <1% 203 $5K
64634 <1% 149 $5K
64450 <1% 121 $4K
01992 <1% 70 $3K
64491 <1% 66 $3K
90832 Psychotherapy session, about 30 minutes <1% 87 $2K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 317 $1K
G2012 Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion <1% 210 $868.01
62369 <1% 57 $788.19
64492 <1% 17 $700.67
J3490 Unclassified drugs <1% 279 $646.33
99443 <1% 83 $450.29
20553 <1% 52 $437.12
99406 <1% 66 $221.17
99153 Mod sedat endo service >5yrs <1% 18 $33.44

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLAL, VISHAL (CEO)
Same official

Other billing entities under LAL, VISHAL

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.